FAS and myeloid sarcoma: The predominant expression of FAS on oligodendrocytes exhibiting early stage type 1 GCIs may indicate that FAS activation could be an active player priming the oligodendrocytes for degeneration as observed in active MS lesions with enhanced FAS expression [34].